Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04374760 · ClinicalTrials.gov registry record · NA
Increasing Cervical Cancer Screening Uptake Among Emergency Department Patients
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 1,116
- Enrollment target
NCT04374760: Completed NA study, sponsored by University of Rochester.
NCT04374760 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 1,116 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (21% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04374760, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,116 participants
- Enrollment target
Study Summary
Invasive cervical cancer is preventable with adequate screening but screening rates are considerably below national goals. Emergency departments care for a disproportionate number of women who are not up to date with recommended cervical cancer screening. This study will evaluate the effectiveness of a mobile technology based behavioral intervention (using text messaging prompts) to increase cervical cancer screening uptake among emergency department patients.
Primary Outcome
The investigators will perform logistic regression comparing the treatment and control conditions on CC screening uptake (defined as either receiving CC screening or scheduling CC screening) at followup. The use of logistic regression, rather than a χ² test of independence, allows for (a) the inclusion of potential relevant covariates in the unlikely case of baseline group differences and (b) the examination of moderation/interaction in later primary analyses. Given the sample size of 1,460 non-
Interventions
- BEHAVIORAL SMS-intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,116 participants |
| Start Date | 2020-12-03 |
| Est. Completion | 2024-01-31 |
| Phase | NA |
What the finished NCT04374760 record still lists
NCT04374760 is an interventional study that assigns participants to a tested intervention. Its 1,116 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (21% lower).
The record links to 0 conditions, and to 1 intervention - of which SMS-intervention is the first listed.
NCT04374760 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04374760 about?
NCT04374760 is a clinical study titled "Increasing Cervical Cancer Screening Uptake Among Emergency Department Patients". Invasive cervical cancer is preventable with adequate screening but screening rates are considerably below national goals. Emergency departments care for a disproportionate number of women who are not up to date with recommended cervical cancer screening. This study will evaluate the effectiveness o...
What is the current status of trial NCT04374760?
This trial is currently completed. It is a NA study. The enrollment target is 1,116 participants. The study started on 2020-12-03. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT04374760?
The interventions under investigation include: SMS-intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04374760?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04374760's enrollment target sits among peer trials
1,116 93rd of 2000 higher than 1,908 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- NCT06618534 · 1,120 participants · Phase 2
Azithromycin for Meningococcal Carriage
- NCT07164131 · 1,120 participants · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI